06.02.2023 - QAPs for HPV Test Verification within Cervical Cancer Screening ProgramMISSISSAUGA, Ontario, Feb. 06, 2023 (GLOBE NEWSWIRE) - Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix), a life sciences innovator, manufacturer, and exporter, . Seite 1
Even though cervical cancer is entirely preventable with the HPV vaccine and regular screening, it continues to kill more than 77,000 women in India every year.
Search jobs 05-May-2021 Latest Study on Cervical Cancer Diagnostic Tests Market 2021 | Global Industry Size, Hinder Growth, Global Trend, Revenue, Manufacturers are DYSIS Medical Ltd., Abbott Laboratories, Becton, Dickinson and Company, The Cooper Companies, Inc., Danaher Corporation
SEATTLE, May 05, 2021, (PHARMIWEB)
Global Cervical Cancer Diagnostic Tests Market, By Test Type (Pap Smear Test, Colposcopy Test, ECC Test, and HPV Test), By Age Group (Age 20 – 40 and Age Above 40), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa), is estimated to be valued at US$ 5,910.2 million in 2020 and is estimated to register a CAGR over 6.2% during the forecast period (2020-2027), as highlighted in a new report published by Coherent Market Insights.